Jump to ContentJump to Main Navigation

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Schlattmann, Peter / Tate, Jillian R. / Tsongalis, Gregory J.

12 Issues per year


IMPACT FACTOR 2014: 2.707
Rank 6 out of 30 in category Medical Laboratory Technology in the 2014 Thomson Reuters Journal Citation Report/Science Edition

SCImago Journal Rank (SJR): 0.860
Source Normalized Impact per Paper (SNIP): 1.046

VolumeIssuePage

Issues

Determination of Nitrite Plus Nitrate and Malondialdehyde in Human Plasma: Analytical Performance and the Effect of Smoking and Exercise

Cristina Vassalle / Valter Lubrano / Antonio L'Abbate / Aldo Clerico

Citation Information: Clinical Chemistry and Laboratory Medicine. Volume 40, Issue 8, Pages 802–809, ISSN (Print) 1434-6621, DOI: 10.1515/CCLM.2002.139, June 2005

Publication History

Published Online:
2005-06-01

Abstract

The aim of this study was to evaluate the analytical performance and clinical usefulness of spectrophotometric assays for the measurement of the plasma levels of nitrite plus nitrate (NOx), and malondialdehyde (MDA), as an index of nitric oxide release and lipid peroxidation, respectively. We studied 30 healthy sedentary volunteers, 12 endurance athletes and 12 regular heavy smokers. The lower limit of quantification for plasma NOx concentration was 1 μmol/l, and linearity was observed from 1 to 40 μmol/l of NOx concentration. Variation in replicate samples within or between days was always below 5%. NOx levels were significantly higher in athletes compared to both control subjects and smokers (p<0.05 and p<0.001, respectively), as well as in healthy subjects compared to smokers (p<0.05). The analytical limit of quantification for plasma MDA concentration was 0.03 μmol/l, and linearity was observed from 0.03 to 20 μmol/l of MDA concentration. Variation in replicate samples within or between runs was <5%. Mean MDA concentration was significantly higher in smokers compared to control subjects and athletes (p<0.001). A significant inverse relationship (p<0.001) was observed when comparing NOx with MDA (r= −0.49) or LDL levels (r= −0.30) in the total population. The assays evaluated in this study proved to be sensitive, specific and practicable, and therefore suitable for routine application in clinical chemistry laboratories and/or physiopathological studies involving human blood

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Alessandro Pingitore, Giuseppina Pace Pereira Lima, Francesca Mastorci, Alfredo Quinones, Giorgio Iervasi, and Cristina Vassalle
Nutrition, 2015, Volume 31, Number 7-8, Page 916
[2]
Cristina Vassalle, Paolo Piaggi, Nathan Weltman, Concetta Prontera, Erika Garbella, Danilo Menicucci, Valter Lubrano, Andrea Piarulli, Cinzia Castagnini, Mirko Passera, Silvia Pellegrini, Maria Rosa Metelli, Remo Bedini, Angelo Gemignani, and Alessandro Pingitore
Biomarkers in Medicine, 2014, Volume 8, Number 6, Page 881
[3]
Silvia Maffei, Antonella Mercuri, Gian Carlo Zucchelli, and Cristina Vassalle
International Journal of Cardiology, 2006, Volume 107, Number 2, Page 194
[4]
Zhu Hong, Luo Hailing, Meng Hui, Zhang Guijie, Yan Leyan, and Yue Dubing
Animal Reproduction Science, 2010, Volume 117, Number 1-2, Page 90
[5]
Richard J. Bloomer and Kelsey H. Fisher-Wellman
Gender Medicine, 2008, Volume 5, Number 3, Page 218
[6]
Tine Lise Larsen, Valentina Nilsen, Dag Olav Andersen, George Francis, Pål Rustad, and Mohammad Azam Mansoor
Clinical Biochemistry, 2008, Volume 41, Number 18, Page 1474
[7]
Jens Lykkesfeldt
Clinica Chimica Acta, 2007, Volume 380, Number 1-2, Page 50
[8]
S. R. McAnulty, P. A. Hosick, L. S. McAnulty, J. C. Quindry, L. Still, M. B. Hudson, A. N. Dibarnardi, G. L. Milne, J. D. Morrow, and M. D. Austin
Applied Physiology, Nutrition, and Metabolism, 2007, Volume 32, Number 6, Page 1148
[9]
Cristina Vassalle, Nicoletta Botto, Maria Grazia Andreassi, Sergio Berti, and Andrea Biagini
Coronary Artery Disease, 2003, Volume 14, Number 3, Page 213
[10]
Cristina Vassalle, Silvano Masini, Clara Carpeggiani, Antonio L'Abbate, Claudio Boni, and Gian Carlo Zucchelli
Clinical Chemistry and Laboratory Medicine, 2004, Volume 42, Number 1
[11]
R. J. Bloomer and K. Fisher-Wellman
Nicotine & Tobacco Research, 2009
[12]
Peri Arbak, Ozlem Yavuz, Neslihan Bukan, Oner Balbay, Füsun Ulger, and Ali Nihat Annakkaya
Journal of Occupational Health, 2004, Volume 46, Number 4, Page 281
[13]
STEVEN R. MCANULTY, JOHN T. OWENS, LISA S. MCANULTY, DAVID C. NIEMAN, JASON D. MORROW, CHARLES L. DUMKE, and GINGER L. MILNE
Medicine & Science in Sports & Exercise, 2007, Volume 39, Number 7, Page 1075
[14]
Ilknur Basyigit, Fusun Yildiz, Mustafa Cekmen, Can Duman, and Olcay Bulut
Drugs in R & D, 2005, Volume 6, Number 2, Page 83
[15]
Cristina Vassalle, Nicoletta Botto, Maria Andreassi, Sergio Berti, and Andrea Biagini
Coronary Artery Disease, 2003, Volume 14, Number 3, Page 213
[16]
V. V. Zinchuk, T. P. Pronko, and M. A. Lis
Clinical Physiology and Functional Imaging, 2004, Volume 24, Number 4, Page 205

Comments (0)

Please log in or register to comment.